Gerry Somers currently serves as the Sr. Director and Head of PDQS Business Solutions at Genentech, where he leverages his extensive expertise in learning and talent development to drive transformative change within the biotechnology sector. With a robust background in creating effective learning strategies, Gerry...
Gerry Somers currently serves as the Sr. Director and Head of PDQS Business Solutions at Genentech, where he leverages his extensive expertise in learning and talent development to drive transformative change within the biotechnology sector. With a robust background in creating effective learning strategies, Gerry has successfully implemented a capability strategy that has empowered a team of 65 professionals to transition from passive learning to active application. This strategic shift not only enhanced productivity but also fostered a culture of continuous improvement and innovation.
At the forefront of his initiatives is the OnePDQ learning strategy, which impacts 175 employees across various functions, ensuring they are equipped with the necessary skills to perform quality work. By utilizing data-driven insights to build cohesive learning cohorts, Gerry has effectively aligned training programs with organizational goals, enhancing both individual performance and overall business outcomes. His commitment to emotional intelligence and creative problem-solving has been instrumental in cultivating high-performing teams that thrive in the fast-paced biopharmaceutical landscape.
Gerry's expertise spans multiple domains, including Managed Care, Manufacturing, Product Development, and Compliance, making him a versatile leader in the industry. His proficiency in instructional design and coaching further amplifies his ability to develop tailored learning solutions that meet the unique needs of diverse teams. As he continues to champion agile methodologies and succession planning, Gerry remains dedicated to fostering a culture of excellence at Genentech, ensuring that the organization remains at the cutting edge of innovation in oncology and beyond.
